Alan Van Goethem

Journal Article
A2
open access

Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation

Alan Van Goethem (UGent) , Jill Deleu (UGent) , Nurten Yigit (UGent) , Celine Everaert (UGent) , Myrthala Moreno-Smith, Sanjeev A Vasudevan, Fjoralba Zeka (UGent) , Fleur Demuynck, Eveline Barbieri, Franki Speleman (UGent) , et al.

(2023) NAR CANCER. 5(1).

Add to list

Circulating microRNA biomarkers for metastatic neuroblastoma

Fjoralba Zeka (UGent) , Alan Van Goethem (UGent) , Tim Lammens (UGent) , Anneleen Decock (UGent) , Hetty Helsmoortel (UGent) , Genevieve Laureys (UGent) , Michael Hogarty, Eveline Barbieri, Jason Shohet, Frank Berthold, et al.

(2018) Advances in Neuroblastoma Research, Congress abstracts.

Add to list

Longitudinal evaluation of murine serum microRNAs as biomarkers for neuroblastoma burden and therapeutic TP53 reactivation

Alan Van Goethem (UGent) , Nurten Yigit (UGent) , Celine Everaert (UGent) , Myrthala Moreno-Smith, Sanjeev A Vasudevan, Fjoralba Zeka (UGent) , Fleur Demunck, Eveline Barbieri, Franki Speleman (UGent) , Pieter Mestdagh (UGent) , et al.

(2018) Advances in Neuroblastoma Research, Congress abstracts.

Add to list

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

Fjoralba Zeka (UGent) , Anneleen Decock (UGent) , Alan Van Goethem (UGent) , Katrien Vanderheyden, Fleur Demuynck, Tim Lammens (UGent) , Hetty Helsmoortel (UGent) , Joëlle Vermeulen, Rosa Noguera, Ana P. Berbegall, et al.

(2018) JCI INSIGHT. 3(23).

Add to list

Pharmacological restoration of tumour suppressor protein p53 in neuroblastoma : seeking synergy and non-invasive biomarkers

Alan Van Goethem (UGent) , Jo Vandesompele (UGent) and Tom Van Maerken (UGent)

(2018) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 12(1). p.26-28

Add to list

Book Chapter

MicroRNA expression analysis using small RNA sequencing discovery and RT-qPCR-based validation

Alan Van Goethem (UGent) , Pieter Mestdagh (UGent) , Tom Van Maerken (UGent) and Jo Vandesompele (UGent)

(2017) Functional genomics : methods and protocols. In Methods in Molecular Biology 1654. p.197-208

Add to list

Journal Article
A1
open access

Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma

Alan Van Goethem (UGent) , Nurten Yigit (UGent) , Myrthala Moreno-Smith, Sanjeev A Vasudevan, Eveline Barbieri, Franki Speleman (UGent) , Jason Shohet, Jo Vandesompele (UGent) and Tom Van Maerken (UGent)

(2017) ONCOTARGET. 8(34). p.57047-57057

Add to list

PhD Thesis

Restoration of p53 in neuroblastoma : seeking synergy and non-invasive biomakers

Alan Van Goethem (UGent)

(2017)

Add to list

EV-TRACK : transparent reporting and centralizing knowledge in extracellular vesicle research

Jan Van Deun (UGent) , Pieter Mestdagh (UGent) , Patrizia Agostinis, Özden Akay, Sushma Anand, Jasper Anckaert, Zoraida Andreu Martinez, Tine Baetens, Els Beghein, Laurence Bertier (UGent) , et al.

(2017) NATURE METHODS. 14(3). p.228-232

Add to list

The HBP1 tumor suppressor is an epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex

Shana Claeys (UGent) , Irina Lambertz (UGent) , Alan Van Goethem (UGent) , Candy Kumps (UGent) , Sara De Brouwer (UGent) , Annelies Fieuw (UGent) , Tom Van Maerken (UGent) , Kristina Althoff, Johannes Schulte, Jean-Baptiste Demoulin, et al.

(2016) Belgian Society of Human Genetics (BeSHG) and the Nederlandse Vereniging voor Humane Genetica (NVHG), 1st Joint meeting, Abstract book.

Academic Bibliography

Alan Van Goethem

Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation

Circulating microRNA biomarkers for metastatic neuroblastoma

Longitudinal evaluation of murine serum microRNAs as biomarkers for neuroblastoma burden and therapeutic TP53 reactivation

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

Pharmacological restoration of tumour suppressor protein p53 in neuroblastoma : seeking synergy and non-invasive biomarkers

MicroRNA expression analysis using small RNA sequencing discovery and RT-qPCR-based validation

Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma

Restoration of p53 in neuroblastoma : seeking synergy and non-invasive biomakers

EV-TRACK : transparent reporting and centralizing knowledge in extracellular vesicle research

The HBP1 tumor suppressor is an epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex

Contents

Support

Contact